Table-II.

Characteristics of the study groups at enrollment.

	VAP(+) (n=56) n (%)	VAP(-) (n=69) n (%)	p
Sex(M)	24(43)	30(43)	1.0
Medical	13(52)	12(48)	0.496
Surgical	30(46.2)	35(53.8)	0.834
Trauma	13(37.1)	22(62.9)	0.494
Abdominal surgery	22(53.7)	19(46.3)	0.184
Enteral nutrition	23(41)	40(58)	0.158
Parenteral nutrition	26(46)	24(35)	0.158
Combined enteral +parenteral	7(12.5)	5(7)	0.158
Other infection	13(23.2)	5(7.2)	0.033*
Antibiotic usage	51(91.1)	58(84.1)	0.286
28-day mortality	27(48.2)	29(42)	0.588
ICU mortality	38(67.9)	35(50.7)	0.068
Hospital mortality	40(71.4)	38(55.1)	0.066

VAP: Ventilator-associated pneumonia.